Advertisement
Screener

Arcus Biosciences, Inc. (RCUS) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

2.3 / 5 stars · 32/71 Roast Me

Arcus Biosciences, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

Arcus Biosciences, Inc. (RCUS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05

  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $0.00.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$1.00M.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $0.00.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $0.00.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $7.00M.
  • Arcus Biosciences, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$6.00M.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month as first filedOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-08-05
-$1.00M
10-Q · filed 2026-08-05
-$1.00M
derived: sum of 3 quarters · filed 2026-08-05
-$1.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$1.00M
10-Q · filed 2026-05-05
-$1.00M
derived: sum of 2 quarters · filed 2026-05-05
-$1.00M
derived: sum of 3 quarters · filed 2026-05-05
-$1.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$0.00
derived: sum of 2 quarters · filed 2026-02-25
$0.00
derived: sum of 3 quarters · filed 2026-08-05
$0.00
10-K · filed 2026-02-25
2025-09-30$0.00
10-Q · filed 2025-10-28
$0.00
derived: sum of 2 quarters · filed 2026-08-05
$0.00
10-Q · filed 2025-10-28
-$1.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$0.00
10-Q · filed 2026-08-05
$0.00
10-Q · filed 2026-08-05
-$1.00M
derived: sum of 3 quarters · filed 2026-08-05
$1.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$0.00
10-Q · filed 2026-05-05
-$1.00M
derived: sum of 2 quarters · filed 2026-05-05
$1.00M
derived: sum of 3 quarters · filed 2026-05-05
$1.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.00M
derived: sum of 2 quarters · filed 2026-02-25
$1.00M
derived: sum of 3 quarters · filed 2026-02-25
$0.00
10-K · filed 2026-02-25
2024-09-30$2.00M
10-Q · filed 2025-10-28
$2.00M
derived: sum of 2 quarters · filed 2025-10-28
$1.00M
10-Q · filed 2025-10-28
$4.00M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$0.00
10-Q · filed 2025-08-06
-$1.00M
10-Q · filed 2025-08-06
$2.00M
derived: sum of 3 quarters · filed 2026-02-25
$3.00M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$1.00M
10-Q · filed 2025-05-06
$2.00M
derived: sum of 2 quarters · filed 2026-02-25
$3.00M
derived: sum of 3 quarters · filed 2026-02-25
$3.00M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$4.00M
derived: sum of 2 quarters · filed 2026-02-25
$4.00M
derived: sum of 3 quarters · filed 2026-02-25
$7.00M
10-K · filed 2026-02-25
2023-09-30$1.00M
10-Q · filed 2024-11-06
$1.00M
derived: sum of 2 quarters · filed 2024-11-06
$4.00M
10-Q · filed 2024-11-06
$6.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$0.00
10-Q · filed 2024-08-08
$3.00M
10-Q · filed 2024-08-08
$5.00M
derived: sum of 3 quarters · filed 2025-02-25
$3.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$3.00M
10-Q · filed 2024-05-08
$5.00M
derived: sum of 2 quarters · filed 2025-02-25
$3.00M
derived: sum of 3 quarters · filed 2025-02-25
$1.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$0.00
derived: sum of 2 quarters · filed 2025-02-25
-$2.00M
derived: sum of 3 quarters · filed 2025-02-25
-$6.00M
10-K · filed 2025-02-25
2022-09-30-$2.00M
10-Q · filed 2023-11-07
-$2.56M
10-Q · filed 2022-11-02
-$4.00M
derived: sum of 2 quarters · filed 2023-11-07
-$8.00M
10-Q · filed 2023-11-07
-$8.54M
10-Q · filed 2022-11-02
-$8.86M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$2.00M
10-Q · filed 2023-08-07
-$2.58M
10-Q · filed 2022-08-03
-$6.00M
10-Q · filed 2023-08-07
-$5.98M
10-Q · filed 2022-08-03
-$6.86M
derived: sum of 3 quarters · filed 2024-02-21
-$6.91M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31-$4.00M
10-Q · filed 2023-05-09
-$3.40M
10-Q · filed 2022-05-09
-$4.86M
derived: sum of 2 quarters · filed 2024-02-21
-$4.91M
derived: sum of 3 quarters · filed 2024-02-21
-$4.95M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31-$864.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
-$910.00K
derived: sum of 2 quarters · filed 2024-02-21
-$954.00K
derived: sum of 3 quarters · filed 2024-02-21
-$1.00M
10-K · filed 2024-02-21
-$1.30M
10-K · filed 2022-02-23
2021-09-30-$46.00K
10-Q · filed 2022-11-02
-$90.00K
derived: sum of 2 quarters · filed 2022-11-02
-$136.00K
10-Q · filed 2022-11-02
-$173.00K
derived: sum of 4 quarters · filed 2022-11-02
2021-06-30-$44.00K
10-Q · filed 2022-08-03
-$90.00K
10-Q · filed 2022-08-03
-$127.00K
derived: sum of 3 quarters · filed 2022-08-03
-$190.00K
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31-$46.00K
10-Q · filed 2022-05-09
-$83.00K
derived: sum of 2 quarters · filed 2022-05-09
-$146.00K
derived: sum of 3 quarters · filed 2022-05-09
-$290.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$100.00K
derived: sum of 2 quarters · filed 2022-02-23
-$244.00K
derived: sum of 3 quarters · filed 2022-02-23
-$20.00K
10-K · filed 2022-02-23
2020-09-30-$63.00K
10-Q · filed 2021-11-08
-$207.00K
derived: sum of 2 quarters · filed 2021-11-08
$17.00K
10-Q · filed 2021-11-08
$28.00K
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30-$144.00K
10-Q · filed 2021-08-05
$80.00K
10-Q · filed 2021-08-05
$91.00K
derived: sum of 3 quarters · filed 2022-02-23
$32.00K
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$224.00K
10-Q · filed 2021-05-05
$235.00K
derived: sum of 2 quarters · filed 2022-02-23
$176.00K
derived: sum of 3 quarters · filed 2022-02-23
$260.00K
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$48.00K
derived: sum of 2 quarters · filed 2022-02-23
$36.00K
derived: sum of 3 quarters · filed 2022-02-23
$171.00K
10-K · filed 2022-02-23
2019-09-30-$59.00K
10-Q · filed 2020-11-05
$25.00K
derived: sum of 2 quarters · filed 2020-11-05
$160.00K
10-Q · filed 2020-11-05
$162.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$84.00K
10-Q · filed 2020-08-06
$220.00K
10-Q · filed 2020-08-06
$221.00K
derived: sum of 3 quarters · filed 2021-02-25
$196.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$136.00K
10-Q · filed 2020-05-05
$137.00K
derived: sum of 2 quarters · filed 2021-02-25
$112.00K
derived: sum of 3 quarters · filed 2021-02-25
$126.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$24.00K
derived: sum of 2 quarters · filed 2021-02-25
-$10.00K
derived: sum of 3 quarters · filed 2021-02-25
-$65.00K
10-K · filed 2021-02-25
2018-09-30-$25.00K
10-Q · filed 2019-11-05
-$11.00K
derived: sum of 2 quarters · filed 2019-11-05
-$66.00K
10-Q · filed 2019-11-05
-$99.00K
derived: sum of 4 quarters · filed 2019-11-05
2018-06-30$14.00K
10-Q · filed 2019-08-06
-$41.00K
10-Q · filed 2019-08-06
-$74.00K
derived: sum of 3 quarters · filed 2019-08-06
-$60.00K
derived: sum of 4 quarters · filed 2019-08-06
2018-03-31-$55.00K
10-Q · filed 2019-05-02
-$88.00K
derived: sum of 2 quarters · filed 2019-05-02
-$74.00K
derived: sum of 3 quarters · filed 2019-05-02
-$63.00K
derived: sum of 4 quarters · filed 2019-05-02
2017-12-31-$33.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05
-$19.00K
derived: sum of 2 quarters · filed 2019-03-05
-$8.00K
derived: sum of 3 quarters · filed 2019-03-05
-$16.00K
10-K · filed 2019-03-05
2017-09-30$14.00K
10-Q · filed 2018-11-08
$25.00K
derived: sum of 2 quarters · filed 2018-11-08
$17.00K
10-Q · filed 2018-11-08
2017-06-30$11.00K
10-Q · filed 2018-08-06
$3.00K
10-Q · filed 2018-08-06
2017-03-31-$8.00K
10-Q · filed 2018-05-09
2016-12-31-$26.00K
10-K · filed 2019-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36